News

Meet us at BALM 2020 Congress | Labquality

Written by Labquality | 01/11/20 22:00

The Baltic Congress in Laboratory Medicine will be held on 6-7 November 2020 as an online event. The scientific program will provide insights into actual topics such as COVID-19, new updates on pediatrics, microbiology, infectiology and the use of new technologies. Labquality will be participating in the Congress as one of the sponsors.

Quality assurance of Covid-19 diagnostic tests

Labquality provides full external quality assessment programs for COVID-19 testing. External quality assessment schemes for SARS-CoV-2 nucleic acid testing and antibodies were introduced already in spring 2020, and an EQA scheme for antigen detection will start in January 2021.

Available External Quality Assessment schemes

  • 5677 SARS-CoV-2, antibodies
  • 5676 SARS-CoV-2, nucleic acid detection
  • 5681 SARS-CoV-2, antigen detection

Read more and download the EQA Product Catalogue 2021

Labquality also provides new high-quality control and reference materials for internal quality control and test verification of COVID-19 diagnostic tests.

Microbix REDx SARS-CoV-2 controls for nucleic acid testing

  • REDx™ SARS-CoV-2 Positive Control and Negative Control
  • REDx™FLOQ® SARS-CoV-2 Swab Positive Control and Swab Negative Control

For more information: info@labquality.fi

 

Juha Wahlstedt

Head of Sales

+358 50 327 5338

Jukka Korhonen

Key Account Manager

+358 50 540 9351